Results per Page:

Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients

Turning grief into purpose
Lynn Lippert started fundraising for research at Fred Hutch as a patient and now her partner, Sal Jepson, continues to donate to honor all that she stood for

10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients

New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation

Fred Hutch Breast Sexual Health Clinic supports patients’ intimacy needs
No matter what stage of treatment, providers create safe space

From overlooked to understood, a Black woman’s case gets the attention it deserves
Partnership is key to making patients of color feel respected

Mammogram vans remove barriers that people face accessing breast cancer screening
Fred Hutch focuses on improving screening in under-resourced communities

A promising antibody-drug conjugate for treating brain metastases in breast cancer patients
From the Hurvitz Lab, Clinical Research Division

Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis
Gillian McDonald chooses Fred Hutch for care, including participating in clinical trials that led to being selected for proton therapy

Sacituzumab govitecán para el cáncer de mama metastásico triple negativo
De la Dra. Sara Hurvitz, División de Investigación Clínica

Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division

Sacituzumab govitecan for metastatic triple-negative breast cancer
From Dr. Sara Hurvitz, Clinical Research Division

Breast cancer screening guidelines change — again
U.S. Preventive Services Task Force recommends mammograms every other year for those at average risk, starting at age 40

Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad

Clinical trials excluding fewer cancer patients with brain ‘mets’
In other news, 1 in 5 people with cancer participate in research studies

The new weight-loss drugs and cancer
What patients and doctors need to know when it comes to the popular new injections and pills

Revealing how cancer cells cooperate — and how to stop them
$1 million from Kleberg Foundation will support Dr. Kevin Cheung’s investigations into the collaborative strategies tumors use to spread and resist treatment

Question? Answers from our cancer experts
What kinds of surgeries are available to help with lymphedema and does insurance usually cover them?